Ouster Inc (OUST) stock shows positive growth on Monday

While Ouster Inc has overperformed by 8.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OUST rose by 128.15%, with highs and lows ranging from $32.95 to $5.84, whereas the simple moving average jumped by 120.17% in the last 200 days.

On June 12, 2025, Cantor Fitzgerald Downgraded Ouster Inc (NASDAQ: OUST) to Neutral. A report published by Oppenheimer on March 27, 2025, Initiated its previous ‘Outperform’ rating for OUST. Cantor Fitzgerald November 11, 2024d the rating to Overweight on November 11, 2024, and set its price target from $12 to $10. Cantor Fitzgerald May 22, 2024d its ‘Overweight’ rating to ‘Neutral’ for OUST, as published in its report on May 22, 2024. Chardan Capital Markets also rated the stock as ‘Buy’.

Analysis of Ouster Inc (OUST)

Further, the quarter-over-quarter increase in sales is 29.86%, showing a positive trend in the upcoming months.

One of the most important indicators of Ouster Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -46.96% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.01, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and OUST is recording 3.27M average volume. On a monthly basis, the volatility of the stock is set at 9.92%, whereas on a weekly basis, it is put at 13.27%, with a gain of 16.70% over the past seven days. Furthermore, long-term investors anticipate a median target price of $28.95, showing growth from the present price of $27.88, which can serve as yet another indication of whether OUST is worth investing in or should be passed over.

How Do You Analyze Ouster Inc Shares?

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 10.37%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 42.44% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Hot this week

Can you still get a good price for Corcept Therapeutics Inc (CORT) Shares at this point?

While Corcept Therapeutics Inc has underperformed by -0.21%, investors...

A stock that deserves closer examination: Geo Group, Inc (GEO)

While Geo Group, Inc has underperformed by -1.01%, investors...

Results from IAC Inc (IAC) show risk

While IAC Inc has underperformed by -0.14%, investors are...

Was anything positive for Sprout Social Inc (SPT) stock last session?

While Sprout Social Inc has overperformed by 0.89%, investors...

Ollies Bargain Outlet Holdings Inc OLLI’s stock price gains traction on Thursday

While Ollies Bargain Outlet Holdings Inc has overperformed by...

Topics

Can you still get a good price for Corcept Therapeutics Inc (CORT) Shares at this point?

While Corcept Therapeutics Inc has underperformed by -0.21%, investors...

A stock that deserves closer examination: Geo Group, Inc (GEO)

While Geo Group, Inc has underperformed by -1.01%, investors...

Results from IAC Inc (IAC) show risk

While IAC Inc has underperformed by -0.14%, investors are...

Was anything positive for Sprout Social Inc (SPT) stock last session?

While Sprout Social Inc has overperformed by 0.89%, investors...

Ollies Bargain Outlet Holdings Inc OLLI’s stock price gains traction on Thursday

While Ollies Bargain Outlet Holdings Inc has overperformed by...

Procept BioRobotics Corp (PRCT)’s stock chart: A technical perspective

While Procept BioRobotics Corp has underperformed by -1.13%, investors...

Chewy Inc (CHWY)’s stock performance: a year in review

While Chewy Inc has overperformed by 2.45%, investors are...

Arcus Biosciences Inc (RCUS)’s stock price in review: A technical analysis

While Arcus Biosciences Inc has overperformed by 0.47%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.